PANCREASE Side Effects

6005659-3 | Diarrhoea, Gait Disturbance, Weight Decreased
on Nov 17, 2008 Female patient from NETHERLANDS , weighting 105.8 lb, was treated with Pancrease (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, gait disturbance, weight decreased. Pancrease dosage: . During the same period patient was treated with IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), IMOVANE (View Imovane Review and Imovane Label ), LIVIAL (View Livial Review and Livial Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), ZYBAN (View Zyban Review and Zyban Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

5512203-3 | Abdominal Distension, Abdominal Pain, Blood Glucose Increased, Electrolyte Imbalance, Ileus
Patient was taking Pancrease (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), blood glucose increased, electrolyte imbalance, ileus on Oct 31, 2007 from UNITED STATES Additional patient health information: Female patient , 79 years of age, weighting 105.8 lb, was diagnosed with carcinoid tumour and. Pancrease dosage: . During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.

5494151-0 | Abdominal Distension, Abdominal Pain, Blood Glucose Increased, Electrolyte Imbalance, Ileus
Adverse event was reported on Oct 12, 2007 by a Female patient taking Pancrease (View Usage) (Dosage: ) was diagnosed with carcinoid tumour and. Location: UNITED STATES , 79 years of age, weighting 105.8 lb, After Pancrease was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), blood glucose increased, electrolyte imbalance, ileus. During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.

5475403-7 | Abdominal Distension, Abdominal Pain, Blood Glucose Increased, Electrolyte Imbalance, Ileus
on Sep 24, 2007 Female patient from UNITED STATES , 79 years of age, weighting 105.8 lb, was diagnosed with carcinoid tumour and was treated with Pancrease (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), blood glucose increased, electrolyte imbalance, ileus. Pancrease dosage: . During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.


5474079-2 | Abdominal Pain, Ileus
on Sep 20, 2007 Female patient from UNITED STATES , 79 years of age, was diagnosed with carcinoid tumour and was treated with Pancrease (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), ileus. Pancrease dosage: . During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.

4992147-6 |
Patient was taking Pancrease (View Usage). on May 02, 2006 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 185.0 lb, was diagnosed with pancreatic insufficiency and. Pancrease dosage: .

4984924-2 | Crohn's Disease
Adverse event was reported on Apr 25, 2006 by a Female patient taking Pancrease (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 89.99 lb, Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?).

4820795-2 | Large Intestinal Ulcer
on Nov 01, 2005 Male patient from UNITED STATES , 29 years of age, was diagnosed with cystic fibrosis and was treated with Pancrease (View Usage). Patient had the following side effects: large intestinal ulcer. Pancrease dosage: . During the same period patient was treated with TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DORNASE ALFA (View Dornase Alfa Review and Dornase Alfa Label ).

4660386-X | Rash Erythematous
on Apr 28, 2005 Male patient from , 60 years of age, was treated with Pancrease (View Usage). After Pancrease was administered, patient had the following side effects: rash erythematous. Pancrease dosage: . Patient was hospitalized.

4649045-7 | Rash Erythematous
Patient was taking Pancrease (View Usage). Patient experienced the following unwanted or unexpected effects: rash erythematous on Apr 14, 2005 from Additional patient health information: Male patient , 60 years of age, . Pancrease dosage: . Patient was hospitalized.

4623767-6 | Infection
Adverse event was reported on Mar 15, 2005 by a Female patient taking Pancrease (View Usage) (Dosage: ) was diagnosed with pancreatic enzyme abnormality and. Location: , 34 years of age, Patient had the following side effects: infection (What is infection?). Patient was hospitalized.